Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
US Department of Justice
Fuji
McKesson
Mallinckrodt
Cantor Fitzgerald
Merck
Boehringer Ingelheim

Generated: November 19, 2018

DrugPatentWatch Database Preview

Arbor Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for ARBOR PHARMS LLC, and when can generic versions of ARBOR PHARMS LLC drugs launch?

ARBOR PHARMS LLC has twenty-two approved drugs.

There are nineteen US patents protecting ARBOR PHARMS LLC drugs.

Summary for Arbor Pharms Llc
US Patents:19
Tradenames:23
Ingredients:15
NDAs:22

Drugs and US Patents for Arbor Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 090533-004 Oct 25, 2011 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Arbor Pharms Llc ERY-TAB erythromycin TABLET, DELAYED RELEASE;ORAL 062298-002 Approved Prior to Jan 1, 1982 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Arbor Pharms Llc ERYTHROCIN STEARATE erythromycin stearate TABLET;ORAL 060359-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Arbor Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Arbor Pharms Llc EDARBYCLOR azilsartan kamedoxomil; chlorthalidone TABLET;ORAL 202331-002 Dec 20, 2011 5,736,555 ➤ Try a Free Trial
Arbor Pharms Llc GLIADEL carmustine IMPLANT;INTRACRANIAL 020637-001 Sep 23, 1996 4,757,128 ➤ Try a Free Trial
Arbor Pharms Llc EDARBI azilsartan kamedoxomil TABLET;ORAL 200796-002 Feb 25, 2011 5,958,961 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ARBOR PHARMS LLC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Lotion 0.5% ➤ Subscribe 2017-09-01

Supplementary Protection Certificates for Arbor Pharms Llc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
12/008 Ireland ➤ Try a Free Trial PRODUCT NAME: AZILSARTAN MEDOXOMIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING THE POTASSIUM SALT; REGISTRATION NO/DATE: EU/1/11/734/001-011 EU/1/11/735/001-011 20111209
6 Finland ➤ Try a Free Trial
962 Luxembourg ➤ Try a Free Trial 91962, EXPIRES: 20261207
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
Cipla
Farmers Insurance
US Department of Justice
Deloitte
US Army
Medtronic
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.